An anti‐tumorigenic effects of bazedoxifene, associated with reduced IL6‐dependent pSTAT3 levels, have been demonstrated in xenograft models of rhabdomyosarcoma (Xiao et al, 2017), pancreatic (Wu et al, 2016), liver (Wang et al, 2017), and colon cancer (Li et al, 2018). This evidence concerns the gene IL6 and rhabdomyosarcoma.